Advertisement

3 Things About DermTech That Smart Investors Know

3 Things About DermTech That Smart Investors Know

DermTech (NASDAQ: DMTK), a company that is trying to redefine testing for skin cancer, has been a sleeper stock for the better half of 2021. The company has created a patch that makes testing for skin cancer easier and more accurate, yet the stock has fallen 60% from its February highs. Here are three things smart investors know before investing in this innovative company.